Cargando…

Janus Faced HMGB1 and Post-Aneurysmal Subarachnoid Hemorrhage (aSAH) Inflammation

Aneurysmal subarachnoid hemorrhage (aSAH), resulting majorly from the rupture of intracranial aneurysms, is a potentially devastating disease with high morbidity and mortality. The bleeding aneurysms can be successfully secured; however, the toxic and mechanical impact of the blood extravasation int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhry, Shafqat Rasul, Shafique, Sumaira, Sajjad, Saba, Hänggi, Daniel, Muhammad, Sajjad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569479/ https://www.ncbi.nlm.nih.gov/pubmed/36232519 http://dx.doi.org/10.3390/ijms231911216

Ejemplares similares

Clustering of serum biomarkers involved in post-aneurysmal subarachnoid hemorrhage (aSAH) complications
por: Fischer, Igor, et al.
Publicado: (2023)

Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2018)

Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021)

Acute Multidisciplinary Management of Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Ran, Kathleen R, et al.
Publicado: (2023)

Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2021)

Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2020)

Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2017)

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
por: Rivero-Arias, Oliver, et al.
Publicado: (2010)

Aneurysmal subarachnoid haemorrhage (aSAH): Five consecutive years' experience of Fars province, Iran
por: Rahmanian, Abdolkarim, et al.
Publicado: (2017)

Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH)
por: Arati, S., et al.
Publicado: (2019)

Blood Pressure Affects the Early CT Perfusion Imaging in Patients with aSAH Reflecting Early Disturbed Autoregulation
por: Hofmann, Björn B., et al.
Publicado: (2023)

The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Context of Aneurysmal Subarachnoid Hemorrhage (aSAH)—A Prospective Observational Study
por: Schmidt, Tobias P., et al.
Publicado: (2022)

Evaluation of MTT Heterogeneity of Perfusion CT Imaging in the Early Brain Injury Phase: An Insight into aSAH Pathopysiology
por: Hofmann, Björn B., et al.
Publicado: (2023)

Inflammation and Anti-Inflammatory Targets after Aneurysmal Subarachnoid Hemorrhage
por: Muhammad, Sajjad, et al.
Publicado: (2021)

Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
por: Muhammad, Sajjad, et al.
Publicado: (2020)

Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review
por: Ahmed, Hammad, et al.
Publicado: (2021)

Is sex a predictor for delayed cerebral ischaemia (DCI) and hydrocephalus after aneurysmal subarachnoid haemorrhage (aSAH)? A systematic review and meta-analysis
por: Rehman, Sabah, et al.
Publicado: (2022)

Vascular Macrophages as Therapeutic Targets to Treat Intracranial Aneurysms
por: Muhammad, Sajjad, et al.
Publicado: (2021)

Initial severity of aneurysmal subarachnoid hemorrhage (SAH): Trend over time
por: Sung, Seung Bin, et al.
Publicado: (2022)

Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
por: Schneider, U.C., et al.
Publicado: (2018)

Early serum miR-1297 is an indicator of poor neurological outcome in patients with aSAH
por: Sheng, Bin, et al.
Publicado: (2018)

Short-term outcomes after repair treatment (clipping or coiling) in aneurysmal subarachnoid hemorrhage (ASAH): a prospective multicenter study
por: Gero Escapa, M, et al.
Publicado: (2015)

Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies
por: Jin, Jing, et al.
Publicado: (2022)

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
por: Rhim, Ha-Young, et al.
Publicado: (2021)

Brain Immune Interactions—Novel Emerging Options to Treat Acute Ischemic Brain Injury
por: Muhammad, Sajjad, et al.
Publicado: (2021)

Should endovascular therapy for cerebral vasospasm coincide with hypervolemic-hypertensive therapy (HT) in aneurysmal subarachnoid hemorrhage (SAH)?
por: Liopyris, P, et al.
Publicado: (1999)

Intracranial Venous Alteration in Patients With Aneurysmal Subarachnoid Hemorrhage: Protocol for the Prospective and Observational SAH Multicenter Study (SMS)
por: Umana, Giuseppe E., et al.
Publicado: (2022)

Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm
por: Juif, Pierre-Eric, et al.
Publicado: (2021)

Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH)
por: Savla, Paras, et al.
Publicado: (2022)

Follow-up of Vasospasm by Transcranial Doppler Sonography (TCD) in Subarachnoid Hemorrhage (SAH)
por: Djelilovic-Vranic, Jasminka, et al.
Publicado: (2017)

Exome sequencing study revealed novel susceptibility loci in subarachnoid hemorrhage (SAH)
por: Hao, Xiwa, et al.
Publicado: (2020)

Development of a patient-reported outcome measure for patients who have recovered from a subarachnoid hemorrhage: the “questionnaire for the screening of symptoms in aneurysmal subarachnoid hemorrhage” (SOS-SAH)
por: Nobels-Janssen, Edith, et al.
Publicado: (2021)

Outcomes of spontaneous subarachnoid hemorrhage (sah) in neurocritical care unit: a multicenter study
por: Iglesias Posadilla, D, et al.
Publicado: (2015)

First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
por: Lilla, Nadine, et al.
Publicado: (2017)

The Janus face of HMGB1 in heart disease: a necessary update
por: Raucci, Angela, et al.
Publicado: (2018)

A novel visual dynamic nomogram to online predict the risk of unfavorable outcome in elderly aSAH patients after endovascular coiling: A retrospective study
por: Lu, Wei, et al.
Publicado: (2023)

Aneurysmal Subarachnoid Hemorrhage
por: D’Souza, Stanlies
Publicado: (2015)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH)
por: Heinz, Rebecca, et al.
Publicado: (2021)

Proposed Definition of Experimental Secondary Ischemia for Mouse Subarachnoid Hemorrhage
por: van Lieshout, Jasper Hans, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gtue6pq4kdq7aa1qcph4jk9ah7